Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. [perioperative Molecular Testing In Non-small Cell Lung Cancer].
  1. Home
  3. [perioperative Molecular Testing In Non-small Cell Lung Cancer].

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pitfalls in Detecting MET Exon 14 Skipping Variants by DNA- and RNA-Based Next-Generation Sequencing Technologies in a Large Real-World Cohort and Results of the First Multinational External Quality Assessment Schemes.

The Journal of molecular diagnostics : JMD·2026
Same author

Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasms.

Neuroendocrinology·2026
Same author

Corrigendum to "Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial" [Radiother. Oncol. 208 (2025) 110907].

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How?

Journal of gastrointestinal cancer·2026
Same author

[Thoracic Surgical Management of Unilateral Symptomatic Diaphragmatic Paralysis: Consensus Statement of an Expert Group Based on the Modified Delphi Method].

Zentralblatt fur Chirurgie·2025
Same author

ASO Visual Abstract: Iterative Hepatic and Pulmonary Metastasectomy in Stage IV Colorectal Cancer: Impact on Survival and Surgical Outcomes.

Annals of surgical oncology·2025
Same journal

Zentralblatt fur Chirurgie·2026
Same journal

Predictive Factors for Mediastinal Lymph Node Metastases in Patients with Non-small Cell Lung Cancer, as Detected by Video-assisted Mediastinoscopic Lymphadenectomy.

Zentralblatt fur Chirurgie·2026
Same journal

[Robotic Management of a Bile Leak After Cholecystectomy Caused by an Aberrant Bile Duct of the Hepatic Segments, Using a Combined Biliodigestive Anastomosis Incorporating the Cystic Duct Stump].

Zentralblatt fur Chirurgie·2026
Same journal

[Microvascular Reconstruction of the Laryngotracheal Junction].

Zentralblatt fur Chirurgie·2026
Same journal

[Evaluation of Multimodal Perioperative Care Pathway Supported by a Patient-facing Mobile App in Colorectal Surgery - First Clinical Experience and Patient Satisfaction].

Zentralblatt fur Chirurgie·2026
Same journal

Zentralblatt fur Chirurgie·2026
See all related articles

Related Experiment Video

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

[Perioperative Molecular Testing in Non-small Cell Lung Cancer].

Uyen-Thao Le, Anne Maria Schultheis, Severin Schmid

    Zentralblatt Fur Chirurgie
    |June 8, 2026

    View abstract on PubMed

    Summary
    This summary is machine-generated.

    Comprehensive molecular profiling of non-small cell lung cancer (NSCLC) is vital for personalized perioperative targeted therapies. Early-stage NSCLC patients benefit from targeted treatments based on molecular alterations, improving survival outcomes.

    Related Experiment Videos

    Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
    07:59

    Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

    Published on: September 8, 2023

    Area of Science:

    • Oncology
    • Genomics
    • Translational Medicine

    Background:

    • Non-small cell lung cancer (NSCLC) presents significant tumor heterogeneity.
    • Molecular alterations in NSCLC impact targeted therapy and immunotherapy efficacy.
    • Perioperative molecular profiling is crucial for optimizing treatment outcomes in early-stage NSCLC.

    Purpose of the Study:

    • To review current evidence on perioperative targeted therapies for NSCLC.
    • To discuss molecular testing recommendations and their therapeutic implications.
    • To highlight ongoing research in targeted therapy for NSCLC.

    Main Methods:

    • Review of current literature on targeted therapies and molecular testing in NSCLC.
    • Discussion of clinical trial results (e.g., ADAURA, ALINA).
    • Analysis of diagnostic techniques for molecular profiling.

    Main Results:

    • Targeted therapies have shown significant improvements in disease-free and overall survival for molecularly altered NSCLC.
    • Osimertinib (EGFR-mutated) and alectinib (ALK-positive) are approved for adjuvant treatment post-resection.
    • Next-generation sequencing panels are the diagnostic gold standard.

    Conclusions:

    • Comprehensive molecular characterization is essential for guiding perioperative treatment decisions in NSCLC.
    • Targeted therapies are increasingly important in the adjuvant and neoadjuvant settings for NSCLC.
    • Continued research is vital to expand the role of targeted therapies in NSCLC management.